Skip to main content
Clinical Trials/ACTRN12611000232932
ACTRN12611000232932
Completed
Not Applicable

In healthy postmenopausal women what are the effects of hydroxyapatite preparations compared with calcium citrate and calcium carbonate on serum calcium and markers of bone turnover?

The University of Auckland0 sites100 target enrollmentMarch 3, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoporosis
Sponsor
The University of Auckland
Enrollment
100
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 3, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Female, postmenopausal 5 years or more (menopause defined as at least 12 months since last period in a woman aged \> 45 yrs with intact uterus, or serum oestradiol \< 100 pmol/l with FSH \> 50 IU/l in younger or hysterectomised woman).

Exclusion Criteria

  • Past history of coronary heart disease, cerebrovascular disease or peripheral vascular disease, estimated 5\-year cardiovascular risk \>15%, renal impairment (serum creatinine \>0\.15 mmol/L), chronic liver disease, untreated hypothyroidism or hyperthyroidism, concurrent major systemic illness (including malignancy), active major gastrointestinal disease, metabolic bone diseases, or serum ALP \>normal, primary hyperparathyroidism, current or expected use of oral glucocorticoid drugs during the trial period, current or past use of bisphosphonate therapy in the preceding 2 years, use of hormone replacement therapy within the last 12 months, use of other medication known to cause osteoporosis or interfere with bone metabolism.

Outcomes

Primary Outcomes

Not specified

Similar Trials